Divani Caravel Hotel,
Athens, 10-12/11/2022
IASIS PHARMA participated actively in the 22nd Panhellenic Hypertension Congress of the Hellenic Society of Hypertension (HSH). The conference was hybrid, i.e. both with the physical presence of the conference participants and its simultaneous webcast, from November 10 to 12, 2022, in Athens, at the DIVANI CARAVEL Hotel.
The 22nd Congress of the Hellenic Society of Hypertension concerned all health professionals involved in the prevention, diagnosis and treatment of hypertension and its complications, with the aim of transferring the most up-to-date theoretical and practical knowledge for the most effective treatment of arterial hypertension in Greece.
IASIS PHARMA participated with an exhibition stand, where the following products were presented:
– Rami-Amlo®, a fixed-dose combination of Ramipril & Amlodipine in a single dosage form, in packages of 28 capsules, available in 4 strengths:
5mg / 5mg,
5mg / 10mg,
10mg / 5mg,
10mg / 10mg.
Rami-Amlo Plus®, also an original fixed-dose combination of Ramipril – Amlodipine –Hydrochlorothiazide, which is available in packages of 30 capsules, in a wide range of strengths:
(Ramipril / Amlodipine / Hydrochlorothiazide)
5 mg / 5 mg / 12,5 mg
5 mg / 5 mg / 25 mg,
10 mg / 5 mg / 25 mg,
10 mg / 10 mg / 25 mg.
Licepler®: Licepler® (eplerenone) available in packages of 30 film-coated tablets, in 25mg and 50mg strengths.
MAG-IASIS® the first uniquely effective combination of 1193.57 mg magnesium citrate & 667.56 mg magnesium aspartate, equivalent to 243 mg Magnesium, indicated for magnesium deficiency, in the form of 40 effervescent tablets.
